Tissue autofluorescence spectroscopy: an intermediate endpoint for chemopreventive agents

Stimson P. Schantz M.D.; Howard E. Savage; Peter G. Sacks; Michael Silverberg; Martin Lipkin; Kan Yang; Gui Chen Tang; Robert R. Alfano

doi:10.1117/12.151181

27 August 1993 Tissue autofluorescence spectroscopy: an intermediate endpoint for chemopreventive agents

Stimson P. Schantz M.D., Howard E. Savage, Peter G. Sacks, Michael Silverberg, Martin Lipkin, Kan Yang, Gui Chen Tang, Robert R. Alfano

Author Affiliations +

Proceedings Volume 1887, Physiological Imaging, Spectroscopy, and Early-Detection Diagnostic Methods; (1993) https://doi.org/10.1117/12.151181
Event: OE/LASE'93: Optics, Electro-Optics, and Laser Applications in Scienceand Engineering, 1993, Los Angeles, CA, United States

Abstract

We report on the fluorescence spectroscopy of a multicellular tumor spheroid treated and non- treated with (beta) -all-trans retinoic acid. Following ten days of treatment with RA (10^-6M), reproducible fluorescent changes were measured using a Mediscience CD scanner. The most significant changes included an increase in emission at 520 nm in the RA treated spheroids when excited at 340 nm. When investigating fluorescence emission at 450 nm, a blue shift in the excitation profile was noted. Molecular alterations induced by RA and as measured by optical fluorescence spectroscopy may arise from qualitative and/or quantitative changes in a number of key molecules involved in cellular differentiation, proliferation and/or electron transfer, i.e. NADH at (450 nm emission), flavins (520 nm), or cytokeratins (520 nm). To further explore alterations of cytokeratins, immunohistochemical staining showed an increase in AE1 positive cells induced by RA which paralleled the increased 520 nm signal. Our results indicate that certain vitamin derivatives are capable of modulating the intrinsic fluorescence profile emitted by neoplastic mucosa. Tissue autofluorescence may represent a significant marker for the biologic effect of cancer preventing agents in clinical trials.

Citation Download Citation

Stimson P. Schantz M.D., Howard E. Savage, Peter G. Sacks, Michael Silverberg, Martin Lipkin, Kan Yang, Gui Chen Tang, and Robert R. Alfano "Tissue autofluorescence spectroscopy: an intermediate endpoint for chemopreventive agents", Proc. SPIE 1887, Physiological Imaging, Spectroscopy, and Early-Detection Diagnostic Methods, (27 August 1993); https://doi.org/10.1117/12.151181

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
10 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Luminescence

Cancer

Tissue optics

Tissues

Fluorescence spectroscopy

Spectroscopy

Molecular spectroscopy

Show All Keywords

Keywords/Phrases

Search In:

Publication Years